Skip to main content
MainBoardListed
Ami Organics Limited Logo

Ami Organics Limited IPO

Ami Organics Limited IPO

IPO Date :
Issue Price :
Allotment Date :
Listing Date :
List Price :
Lot Size:
Subscription:
Listed Price: ₹ 910.00 (+49.18%)

Ami Organics Limited's achieved publicly listed status following its IPO debut on 14-09-2021 at the NSE, BSE platform. The offering successfully mobilized 93,38,288 Shares, with 32,78,688 Shares allocated to corporate growth initiatives and ₹370.00 Cr providing liquidity to existing shareholders.

Investment participation occurred within the established price band of ₹603 to ₹610, starting from minimum lots of 24 shares. The subscription window from 01-09-2021 through 03-09-2021 enabled investor participation across market segments.

Share allocation was completed on 08-09-2021, determining ownership distribution among successful applicants. The listing represents a milestone achievement, transitioning the company to regulated public market status with associated responsibilities and opportunities.

Ami Organics IPO Details
Lot(s) Distribution

Investors can bid starting from the minimum lot size specified for this IPO, and only in multiples of that lot size. The table below shows the minimum and maximum investment for retail investors and HNIs in terms of lots, quantity, and amount.

IPO Reservation
Ami Organics IPO Key Performance Indicator
Company Financials ( In Lakhs )

Ami Organics IPO About Company

Incorporated in 2004, Ami Organics Limited is a research-driven manufacturer of specialty chemicals, producing advanced pharmaceutical intermediates, active pharmaceutical ingredients (APIs) for new chemical entities, and materials for agrochemicals and fine chemicals. The company has developed over 450 pharma intermediates across 17 therapeutic areas, including anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant, and anti-coagulant, supplying more than 150 domestic and international customers across 25 countries, including Europe, the USA, China, Israel, Japan, and Latin America. Its manufacturing operations are based in Gujarat at Sachin, Ankleshwar, and Jhagadia, with a combined installed capacity of 6,060 MTPA.


Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."


Ami Organics IPO Strength Factors

  1. Leading Manufacturer: Produces key pharma intermediates like Dolutegravir, Trazodone, Entacapone, Nintedanib, and Rivaroxaban.
  2. Diversified Portfolio: Offers 450+ pharma intermediates across 17 therapeutic areas.
  3. Wide Presence: Extensive geographic reach with a diverse customer base.
  4. Strong Capabilities: Robust R&D, sales, and marketing expertise.
  5. Consistent Financials: Demonstrates a reliable track record of financial performance.

Ami Organics IPO Risk Factors

NA


Ami Organics IPO Lead Manager(s)

  • Ambit Private Limited
  • Axis Capital Limited
  • Intensive Fiscal Services Private Limited

Ami Organics IPO Promoter(s)

  1. Nareshkumar Ramjibhai Patel
  2. Chetankumar Chhaganlal Vaghasia
  3. Shital Nareshbhai Patel
  4. Parul Chetankumar Vaghasia

Ami Organics IPO Company Details

Ami Organics Limited
Phone:
address:

Ami Organics IPO Registrar

Link Intime India Private Limited
Name:
Phone:

Ami Organics IPO FAQs